Longeveron Bolsters Market Position With Strategic Financing

TipRanksApr 19 04:43

Longeveron Raises A Total Of $11.4M In Gross Proceeds From Warrant Exercise Offering And Public Offering

Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hy

BenzingaApr 19 04:09

Peering Into Longeveron's Recent Short Interest

Longeveron's (NYSE:LGVN) short percent of float has fallen 83.09% since its last report. The company recently reported that it has 28 thousand shares sold short, which is 2.79% of all regular shares t

BenzingaApr 19 00:00

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of The Travelers Companies, Inc. (NYSE:TRV) fell sharply during Wednesday's session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' e

BenzingaApr 18 01:36

Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.32% to 37,678.27 while the NASDAQ fell 1.16% to 15,681.95. The S

BenzingaApr 18 00:44

Longeveron Shares Drop 31% After Exercise of Warrants

By Chris Wack Longeveron shares were down 25% to $2.65 after the company exercised certain existing warrants to buy 2.4 million shares at an exercise price of $2.35 a share The biotechnology company

WSJApr 17 22:19